Mostrar el registro sencillo

dc.contributor.authorLipps, Christophes_ES
dc.contributor.authorKlein, Franziskaes_ES
dc.contributor.authorWahlicht, Tomes_ES
dc.contributor.authorSeiffert, Virginiaes_ES
dc.contributor.authorButueva, Miladaes_ES
dc.contributor.authorZauers, Jeannettees_ES
dc.contributor.authorTruschel, Theresaes_ES
dc.contributor.authorLuckner, Martines_ES
dc.contributor.authorKöster, Marioes_ES
dc.contributor.authorMacLeod, Roderickes_ES
dc.contributor.authorPezoldt, Jörnes_ES
dc.contributor.authorHühn, Jochenes_ES
dc.contributor.authorYuan, Qinggonges_ES
dc.contributor.authorMüller, Peter Paules_ES
dc.contributor.authorKempf, Henninges_ES
dc.contributor.authorZweigerdt, Robertes_ES
dc.contributor.authorDittrich-Breiholz, Oliveres_ES
dc.contributor.authorPufe, Thomases_ES
dc.contributor.authorRiancho Moral, José Antonio es_ES
dc.contributor.authorSañudo Campo, María Carolina es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2019-02-05T18:12:23Z
dc.date.available2019-02-05T18:12:23Z
dc.date.issued2018es_ES
dc.identifier.issn2041-1723es_ES
dc.identifier.urihttp://hdl.handle.net/10902/15667
dc.description.abstractFundamental research and drug development for personalized medicine necessitates cell cultures from defined genetic backgrounds. However, providing sufficient numbers of authentic cells from individuals poses a challenge. Here, we present a new strategy for rapid cell expansion that overcomes current limitations. Using a small gene library, we expanded primary cells from different tissues, donors, and species. Cell-type-specific regimens that allow the reproducible creation of cell lines were identified. In depth characterization of a series of endothelial and hepatocytic cell lines confirmed phenotypic stability and functionality. Applying this technology enables rapid, efficient, and reliable production of unlimited numbers of personalized cells. As such, these cell systems support mechanistic studies, epidemiological research, and tailored drug development.es_ES
dc.description.sponsorshipAcknowledgements: This work was supported by grants from the Niedersächsisches Ministerium für Wissenschaft und Kultur (80029155), the German Ministry for Economic Affairs and Energy (IGF 16153 N) and the German Ministry for Research and Education (FKZ 0316037). The authors further acknowledge funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and WI2648/3-1. Further, T. Wahlicht, F. Klein M. Butueva, and C. Lipps wish to acknowledge the support by the HZI GradSchool and the PhD program Regenerative Sciences within the Hannover Biomedical Research School (HBRS). J.A. Riancho and C. Sañudo have support from Instituto de Salud Carlos III/FEDER funds (PI 12/615) and from IDIVAL. B. Opalka thanks Sana Mohamad for technical assistance und B.Opalka, J.R.Göthert, and V.Rebmann thank Ulrich Dührsen and Peter Horn for ongoing support. R.A.F. MacLeod acknowledges support of the Leukemia and Lymphoma Society of America and the expert technical help of Karen Kaufmann.es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceNature Communications 2018; 9(1):994es_ES
dc.titleExpansion of functional personalized cell systems with specific transgene combinationses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://dx.doi.org/10.1038/s41467-018-03408-4es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1038/s41467-018-03408-4es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International